These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33823377)

  • 1. Amelioration of Levetiracetam-Induced Behavioral Side Effects by Pyridoxine. A Randomized Double Blind Controlled Study.
    Mahmoud A; Tabassum S; Al Enazi S; Lubbad N; Al Wadei A; Al Otaibi A; Jad L; Benini R
    Pediatr Neurol; 2021 Jun; 119():15-21. PubMed ID: 33823377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridoxine for treatment of levetiracetam-induced behavioral adverse events: A randomized double-blind placebo-controlled trial.
    Cheraghmakani H; Rezapour M; Asghari F; Alizadeh-Navaei R; Ghazaeian M; Tabrizi N
    Epilepsy Behav; 2022 Nov; 136():108938. PubMed ID: 36228485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results.
    Major P; Greenberg E; Khan A; Thiele EA
    Epilepsy Behav; 2008 Oct; 13(3):557-9. PubMed ID: 18647662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current evidence for adjunct pyridoxine (vitamin B6) for the treatment of behavioral adverse effects associated with levetiracetam: A systematic review.
    Besag FMC; Vasey MJ; Sen A
    Epilepsy Behav; 2023 Mar; 140():109065. PubMed ID: 36791631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of levetiracetam mitigated by pyridoxine.
    Davis GP; McCarthy JT; Magill DB; Coffey B
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):209-11. PubMed ID: 19364300
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyridoxine supplementation for levetiracetam-related neuropsychiatric adverse events: A systematic review.
    Romoli M; Perucca E; Sen A
    Epilepsy Behav; 2020 Feb; 103(Pt A):106861. PubMed ID: 31917143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxine Add-On Treatment for the Control of Behavioral Adverse Effects Induced by Levetiracetam in Children: A Case-Control Prospective Study.
    Marino S; Vitaliti G; Marino SD; Pavone P; Provvidenti S; Romano C; Falsaperla R
    Ann Pharmacother; 2018 Jul; 52(7):645-649. PubMed ID: 29442544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Pyridoxine Successfully Reduce Behavioral Side Effects from Levetiracetam?: A Critically Appraised Topic.
    Chhabra N; Vanood A; Hoerth MT; Sanchez CV; O'Carroll CB
    Neurologist; 2023 Sep; 28(5):349-352. PubMed ID: 37083708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin B6 decreases the risk of levetiracetam discontinuation in children with epilepsy: A retrospective study.
    Lob K; Bassell-Hawkins J; Patil R; Nie D; Bartolini L
    Epilepsy Behav; 2022 Sep; 134():108839. PubMed ID: 35839645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
    Foo EC; Geldard J; Peacey C; Wright E; Eltayeb K; Maguire M
    Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Controlled Trial of Phenobarbital and Levetiracetam in Childhood Epilepsy.
    Akter N; Rahman MM; Akhter S; Fatema K
    Mymensingh Med J; 2018 Oct; 27(4):776-784. PubMed ID: 30487494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
    Schoedel KA; Stockis A; Sellers EM
    Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations Regarding Recently Published Amelioration of Levetiracetam-Induced Behavioral Side Effects by Pyridoxine.
    García FG; Cardon M; Cardon AL
    Pediatr Neurol; 2022 Jan; 126():56. PubMed ID: 34740133
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review.
    Halma E; de Louw AJ; Klinkenberg S; Aldenkamp AP; IJff DM; Majoie M
    Seizure; 2014 Oct; 23(9):685-91. PubMed ID: 24981629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Vitamin B6 (Pyridoxine) and a B Complex Preparation on Dreaming and Sleep.
    Adventure-Heart DJ; Madden NA; Delfabbro P
    Percept Mot Skills; 2018 Jun; 125(3):451-462. PubMed ID: 29665762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose pyridoxine treatment for inherited glycosylphosphatidylinositol deficiency.
    Tanigawa J; Nabatame S; Tominaga K; Nishimura Y; Maegaki Y; Kinosita T; Murakami Y; Ozono K
    Brain Dev; 2021 Jun; 43(6):680-687. PubMed ID: 33824024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.
    Schiemann-Delgado J; Yang H; Loge Cde L; Stalvey TJ; Jones J; Legoff D; Mintz M
    J Child Neurol; 2012 Jan; 27(1):80-9. PubMed ID: 21876066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does pyridoxine control behavioral symptoms in adult patients treated with levetiracetam? Case series from UAE.
    Alsaadi T; El Hammasi K; Shahrour TM
    Epilepsy Behav Case Rep; 2015; 4():94-5. PubMed ID: 26543816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of levetiracetam because of behavioral side effects: a case-control study.
    White JR; Walczak TS; Leppik IE; Rarick J; Tran T; Beniak TE; Matchinsky DJ; Gumnit RJ
    Neurology; 2003 Nov; 61(9):1218-21. PubMed ID: 14610123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.